Huntington Disease-Like 1 (HDL1) is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Huntington Disease-Like 1 (HDL1) is a rare autosomal dominant neurodegenerative disorder that clinically mimics Huntington's disease but is caused by mutations in the prion protein gene (PRNP). It is classified as a genetic prion disease and is characterized by a choreiform movement disorder, psychiatric disturbances, and progressive cognitive decline[@novel].
Genetics and Molecular Basis
HDL1 is caused by an octapeptide repeat insertion mutation in the PRNP gene located on chromosome 20p13[^2]. The normal PRNP gene contains five octapeptide repeats (PHGGGWGQ), and HDL1 is associated with additional repeats (typically 7-9 repeats) that lead to abnormal prion protein (PrP<sup>Sc</sup>) aggregation[^3].
The inserted repeats create a expanded polyglutamine-like sequence that promotes protein misfolding and aggregation, similar to the mechanism seen in Huntington's disease[^4].
Clinical Presentation
Core Symptoms
...
Huntington Disease-Like 1 (HDL1)
Overview
Huntington Disease-Like 1 (HDL1) is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Huntington Disease-Like 1 (HDL1) is a rare autosomal dominant neurodegenerative disorder that clinically mimics Huntington's disease but is caused by mutations in the prion protein gene (PRNP). It is classified as a genetic prion disease and is characterized by a choreiform movement disorder, psychiatric disturbances, and progressive cognitive decline[@novel].
Genetics and Molecular Basis
HDL1 is caused by an octapeptide repeat insertion mutation in the PRNP gene located on chromosome 20p13[^2]. The normal PRNP gene contains five octapeptide repeats (PHGGGWGQ), and HDL1 is associated with additional repeats (typically 7-9 repeats) that lead to abnormal prion protein (PrP<sup>Sc</sup>) aggregation[^3].
The inserted repeats create a expanded polyglutamine-like sequence that promotes protein misfolding and aggregation, similar to the mechanism seen in Huntington's disease[^4].
Clinical Presentation
Core Symptoms
Patients with HDL1 typically present in the third to fifth decade of life with a combination of:
Movement Disorders
Chorea (involuntary dance-like movements)
Dystonia
Bradykinesia
Gait disturbance
Dysarthria
Psychiatric Manifestations
Depression
Anxiety
Personality changes
Psychosis
Behavioral disinhibition
Cognitive Decline
Executive dysfunction
Memory impairment
Progressive dementia
Impaired judgment and planning
Disease Progression
HDL1 follows a progressive course similar to Huntington's disease, with gradual worsening over 10-20 years. The average age of onset is typically between 30-50 years, with disease duration ranging from 5 to 20 years[^5].
Neuropathology
Gross Pathology
Brain atrophy predominantly affecting the caudate nucleus and putamen (striatum)
Cortical atrophy, particularly in frontal and temporal regions
Vacuolation (spongiform changes) characteristic of prion diseases
Microscopic Findings
Neuronal loss in the basal ganglia and [cortex](/brain-regions/cortex)
Prion protein deposition with amyloid plaque formation
Astrocytic gliosis
Synaptic degeneration
The neuropathological features share characteristics with both Huntington's disease (striatal atrophy) and other prion diseases (spongiform change, PrP deposition)[^6].
Differential Diagnosis
HDL1 must be distinguished from:
| Condition | Key Differentiating Features | |-----------|------------------------------| | Huntington's disease | [HTT](/proteins/huntingtin) gene CAG expansion, no PrP deposition | | HDL2 (JPH3 mutation) | JPH3 gene mutation, African ancestry link | | Other prion diseases | Specific clinical and pathological features | | Spinocerebellar ataxias | Different genetic mutations, ataxia prominent | | Wilson's disease | Copper metabolism abnormalities, Kayser-Fleischer rings |
Diagnosis
Clinical Criteria
Progressive chorea and movement disorder
Psychiatric symptoms
Cognitive decline
Family history (autosomal dominant pattern)
Genetic Testing
PRNP gene sequencing to identify octapeptide repeat insertions
CAG repeat expansion testing to rule out Huntington's disease
Predictive testing for at-risk individuals
Neuroimaging
MRI brain: Striatal atrophy, cortical thinning
PET/SPECT: Reduced metabolism in basal ganglia
PrP PET ligands: Emerging biomarkers for prion protein deposition[^7]
Immunotherapy: Anti-PrP antibodies under development
Gene therapy: Targeting PRNP expression
Supportive Care
Multidisciplinary neurology and psychiatry care
Physical therapy for mobility
Speech therapy for dysarthria
Nutritional support
Genetic counseling for families
Epidemiology
HDL1 is extremely rare, with only a few families reported worldwide. The prevalence is estimated at less than 1 in 1,000,000. Cases have been reported primarily in families of European descent[^8].
Animal Models
Transgenic mouse models carrying human PRNP with octapeptide repeat insertions have been developed and show features mimicking HDL1, including progressive neurological dysfunction and prion protein aggregation[^9].
Research Directions
Active Research Areas
Prion protein aggregation mechanisms
Novel anti-prion compounds
PrP-PET imaging biomarkers
Gene silencing approaches
Stem cell models
Clinical Trials
Currently, no clinical trials are specifically targeting HDL1. Patients may be eligible for trials targeting other prion diseases or Huntington's disease symptomatic treatments.
This section highlights recent publications relevant to this disease.
[A novel 8-octapeptide repeat insertion in PRNP causing Huntington disease-like 1 in a Chinese family: a case report and literature review.](https://pubmed.ncbi.nlm.nih.gov/40461170/) (2025 Sep 19) - Journal of medical genetics
References
[Unknown, A novel 8-octapeptide repeat insertion in PRNP causing Huntington disease-like 1 in a Chinese family: a case report and literature review (n.d.)](https://pubmed.ncbi.nlm.nih.gov/40461170/)